Abstract
U.S. consumers spend more than $6 billion annually on omega-3 fatty acid (n-3FA) dietary supplements and fortified foods, plus another $916 million on prescription fish oil capsules.1 Many n-3FA supplements are available OTC. Two prescription formulations, omega-3-acid ethyl esters (Lovaza—GlaxoSmithKline) and icosapent ethyl (Vascepa— Amarin Pharma), also are currently available.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.